Genetron Health Company

Genetron Health is a world-leading expert in precision medicine.They are committed to developing health management products that cover all elements of full-cycle cancer clinical treatment (including risk assessment, early screening, molecular pathology diagnosis, medication guidance and prognosis monitoring) and effectively applying genomic data to assist medical experts and research scientists. Additionally, they provide cancer patients and high-risk and healthy individuals with reliable molecular clinical services and professional cancer genetic risk assessment.In just three years, Genetron Health has built global genomics sequencing and bioinformatics platforms, established two research and development centers in both North Carolina, U.S., and Beijing, China, and set up clinical laboratories in Beijing, Shanghai, Hangzhou and Chongqing of over 10,000 square meters.In the future, Genetron Health will spread its sales network throughout China with professional marketing, product management, medical experts and scientific research teams, and will provide service for Chinese and global cancer patients with its strong foundation in cancer genomics and efficient clinical translation.

Investors

Funding Status: IPO
Headquarters: China
Founded Date: 41275
Employee Number: 501-1000
Last Funding Type: Series D
Total Funding: $132M
Estimated Revenue: $1M to $10M
Industry: Clinical Trials, Health Care, Medical, Medical Device
Investors Number: 10
Technology: other
Investor Type: For Profit
Last Funding Date: 2019-11-21
Register and Claim Ownership